Mukhtar Ahmad Dar

About

PhD Scholar at National Institute of Pharmaceutical Education and Research (NIPER), Hajipur. Currently working at Mahavir Cancer Research Sansthan and Research Centre (MCSRC), Patna India. Primary research objectives include the assessment of financial burden among cancer patients and its impact on Health-related Quality of Life (HRQoL).
Areas of research interest include Patient Reported Outcome Measures (PROMs), Health-Related Quality of Life Research (HRQoL), Health Economics, Epidemiology

Employment

• National Institute of Pharmaceutical Education and Research Hajipur PhD SCHOLAR
  2017 - Present

Education

• National Institute of Pharmaceutical Education and Research M. Pharm
  2014 - 2016
• University of Kashmir B. Pharm
  2009 - 2013

Projects & Funding

Projects & funding information is unavailable.

Publications (11)

• Assessing the Prevalence of Financial Toxicity, its Predictors and Association with Health- Related Quality of Life Among Radiation Oncology Patients in India: A Cross-Sectional Patient Reported Outcome Study
  International Journal of Radiation Oncology*Biology*Physics 2023 DOI: 10.1016/j.ijrobp.2022.11.040
  +Save
• Development and Validation of Subjective Financial Distress Questionnaire (SFDQ): A Patient Reported Outcome Measure for Assessment of Financial Toxicity among Radiation Oncology Patients
  Frontiers in Oncology 2022
  +Save
• Menace of antimicrobial resistance in LMICs: Current surveillance practices and control measures to tackle hostility
  Journal of Infection and Public Health 2022 DOI: 10.1016/j.jiph.2021.12.008
  +Save
• Safety, efficacy, and immunogenicity of COVAXIN: A review
  Journal of Applied Pharmaceutical Science 2021 DOI: 10.7324/japs.2021.1101103
  +Save
• 28th Annual Conference of the International Society for Quality of Life Research
  Quality of Life Research 2021 DOI: 10.1007/s11136-021-02976-1
  +Save
• Assessing the reliability and validity of comprehensive score for financial toxicity (COST) among radiation oncology patients in India: a cross-sectional pilot study
  ecancermedicalscience 2021 DOI: https://doi.org/10.3332/ecancer.2021.1219
  +Save
• Assessment of Adverse Drug Reactions due to Antimicrobial Drugs in Medicine Inpatients at a Tertiary Care Public Teaching Hospital
  IJMSCRR 2021
  +Save
• Assessment of contraceptive utilization and associated factors among sexually active HIV-positive Indian women: A cross-sectional study from an antiretroviral therapy center
  Clinical Epidemiology and Global Health 2020 DOI: https://doi.org/10.1016/j.cegh.2020.100682
  +Save
• Burden of cancer in India: GLOBOCAN 2018 Estimates
  International Journal of Emerging Technologies and Innovative Research 2019 DOI: http://doi.one/10.1729/Journal.22750
  +Save
• Causality, severity and preventability profiling of adverse drug reactions among medicine inpatients in a tertiary care public teaching hospital, India
  8th Global Pharmacovigilance and Drug Safety Summit 2017 DOI: DOI: 10.4172/2167-0870-C1-017
  +Save